US Stock MarketDetailed Quotes

ARCT Arcturus Therapeutics

Watchlist
  • 11.580
  • -0.420-3.50%
Close Mar 28 16:00 ET
  • 11.010
  • -0.570-4.92%
Post 20:01 ET
314.05MMarket Cap-3.86P/E (TTM)

Arcturus Therapeutics Key Stats

Arcturus Therapeutics Q4 2024 Earnings Date

Currency:USDMar 6, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
44.64M
22.77M
-21.88M
Miss Est.
+31.34%
-26.22%
-49.00%
EPS
-0.48
-1.11
-0.63
Miss Est.
-50.02%
-246.88%
-131.30%
Strong Buy

Mar 28, 2025

Arcturus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 20.088M--
--2025/Q1-- / 25.642M--
Mar 6, 20252024/Q422.766M / 44.642M--
Nov 7, 20242024/Q341.673M / 36.592M--
Aug 5, 20242024/Q249.859M / 22.234M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 20.088M--
--2025/Q1-- / 25.642M--
Mar 6, 20252024/Q422.766M / 44.642M--
Nov 7, 20242024/Q341.673M / 36.592M--
Aug 5, 20242024/Q249.859M / 22.234M--

Unlock Free Earnings Estimates

Arcturus Therapeutics Earnings Reports

Read more

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More